Information
- Price Free
- Language English
- Commitment: Oct 30th, 2022 to Sep 1st, 2023
About this Course
The International Retinoblastoma Comprehensive Course (IRBCC) was designed to serve as a foundational element for eye cancer specialists. It was prepared by more than 50 internationally renowned experts to provide detailed practical guidance and advice on the diagnosis and management of retinoblastoma (RB). Course graduates will acquire state-of-the-art knowledge on the genetics, pathogenesis, diagnosis and treatment of this life-threatening childhood cancer. This course was devised to reduce the world-wide mortality and vision loss associated with this cancer in both developing and developed countries. IRBCC offers the latest knowledge in a format that allows for rapid retrieval of information in daily practice. Graduates of this course will be able to classify, diagnose, and consider most suitable treatment options for differently staged retinoblastomas. By reading and watching IRBCC videos, graduates will have been introduced to retinoblastoma specialists around the world.
Meet the Faculty
DR. PAUL T. FINGER
MD, FACSDr. Paul T. Finger, MD, FACS, is an ophthalmologist, who has specialized in ocular oncology (ocular tumor, orbital disease and ophthalmic radiation therapy). A Clinical Professor of Ophthalmology at the New York University School of Medicine, he is also the director of The New York Eye Cancer Center and Ocular Tumor Services at The New York Eye and Ear Infirmary of Mt. Sinai. He consults for Northwell Health Complex of affiliated Hospitals including Manhattan Eye, Ear and Throat Hospital. Founding The Eye Cancer Foundation, Dr. Finger has directed this charity to support international multicenter cooperation and outreach to underserved and underserved countries. As a foundational element to his international work, he has served two terms as Chair of the American Joint Committee on Cancer (AJCC) Ophthalmic Oncology Task Force (OOTF) that under his guidance developed the first consensus staging system for ocular cancers which has been adopted by the Union International for Cancer Control (UICC). Similarly, Dr. Finger was invited to Chair and thus formed an OOTF for The American Brachytherapy Society (ABS) and American Association of Physicists in Medicine (AAPM) that provided international consensus guidelines for ophthalmic plaque brachytherapy for choroidal melanoma and retinoblastoma. In recognition of his expertise in ophthalmic radiation therapy and medical physics, Dr. Finger was the first ophthalmologist to ever serve on an AAPM Task Group-129 (TG-129) that produced both dosimetry and quality assurance standards for plaque brachytherapy. Read More
DR. YACOUB A. YOUSEF
Dr. Yacoub A. Yousef has created the leading ocular oncology training service in the Middle East, supported (in part) by The Eye Cancer Foundation, Dr. Yousef heads the Retinoblastoma Service and the Ocular Oncology Unit at King Hussein Cancer Center (Amman, Jordan). He completed his basic medical education from The University of Jordan, and The Higher Specialization in Ophthalmology from The Jordan University Hospital. He completed his fellowship in Ocular Tumor, Orbital Disease and Ophthalmic Radiation Therapy at The New York Eye Cancer Center (NY, USA) followed by a fellowship in Retinoblastoma and Ocular Oncology at University of Toronto (Canada) under supervision of the world leaders in the field Dr. Paul Finger and Dr. Brenda Gallie. Since, 2012, Dr. Yousef has been caring for eye cancer patients, teaching and publishing research as faculty at King Hussein Cancer Centre. Read More
DR. SWATHI KALIKI
Dr. Swathi Kaliki is an internationally recognized Ocular Oncologist. She currently heads the Operation Eyesight Universal Institute for Eye Cancer and the Ophthalmic Plastic Services at LV Prasad Eye Institute, India. She completed her basic medical education from Rajiv Gandhi University of Medical Sciences, Bangalore and M.S. Ophthalmology from NTR University of Health Sciences, Hyderabad. She completed her fellowship in Oculoplasty at LV Prasad Eye Institute in 2010. She was later trained in Ocular Oncology by the World leaders, Dr Jerry Shields and Dr Carol Shields at Wills Eye Institute, Philadelphia, USA in 2011. She was also trained in Ocular pathology by the World-renowned ocular pathologist Dr Ralph Eagle Jr at Wills Eye Institute, Philadelphia, USA in 2012. She then joined as a faculty at LV Prasad Eye Institute since 2013. Read More
DR. SAIMA AMINE
MDDr. Saima Amin, MD is recognized as a Pediatric Ophthalmologist in Pakistan. She is heading the department of Pediatric Ophthalmology and Pediatric Ocular Oncology services at the Layton Rehmatullah Benevolent Trust Karachi, Pakistan. Saima completed her basic Ophthalmology training and fellowship in Pediatric Ophthalmology by the College of Physician and Surgeon Pakistan. She further underwent fellowship training (supported by The Eye Cancer Foundation and the International Council of Ophthalmology) in Ocular Oncology at the King Hussein Cancer Center, Jordan. Saima is the first recognized ocular oncologist in Pakistan, and is offering pediatric ocular oncology services to all the major governmental and nonprofit organizations. Email: ophthalmologist2016@gmail.com
DR. ANKIT S. TOMAR
Dr. Ankit Singh Tomar is an Ocular Oncology and Oculoplastics specialist from India. He has completed his medical degree from Seth G. S. Medical College, Mumbai, and Ophthalmology residency from All India Institute of Medical Sciences, New Delhi. He has completed two ophthalmic oncology fellowships, first in Oculoplastics and Ocular Oncology at the Center for Sight under Dr. Santosh Honavar, Hyderabad, India and the Ocular tumor, Orbital disease and Ophthalmic radiation therapy at The New York Eye Cancer Center under Dr. Paul T. Finger, New York. His research work with the American Joint Committee on Cancer - Ophthalmic Oncology Task Force on the multicenter international registry has improved retinoblastoma staging and answered important questions about the diagnosis and management of retinoblastoma. Email: atomar@eyecancer.com
DR. IDO DIDI FABIAN
MDDr. Ido Didi Fabian received his MD from the Technion, Israel. He trained in ophthalmology at Sheba Medical Center, where he now serves as a consultant ocular oncologist. In 2014, he joined the London Ocular Oncology Service for a three-year eye cancer fellowship program. Dr. Fabian is also affiliated to the London School of Hygiene & Tropical Medicine, and serves as the principal investigator of the Rb-NET. He founded in 2017 the Global Retinoblastoma Study Group with nearly 500 collaborators from 130 countries, and initiated the Rb-NET MDT Project in 2020, to assist retinoblastoma treatment centers from low- and middle-income countries. Email: didi@didifabian.com
DR. SONAL P. YADAV
Dr Sonal P. Yadav is a consultant ophthalmic plastic surgeon, orbit and ocular oncologist working in PBMA’s H. V. Desai Eye Hospital, Pune, India. She has completed her fellowship in ocular tumor, orbital diseases and ophthalmic radiation therapy at The New York Eye Cancer Center, New York, USA (2016-17) after completing a fellowship in ophthalmic plastic surgery and ocular oncology at the Centre For Sight Super-Specialty Eye Hospital, Hyderabad (2015-16). She graduated with M.B.B.S. from Seth G. S. Medical College and K.E.M. Hospital, Mumbai in 2010 and then received her post-graduate training in Ophthalmology (M.S.) at the Govt. Medical College and Hospital, Aurangabad, where she was ranked 3rd in Maharashtra University of Health Sciences (M.U.H.S.) in 2013. Read More
DR. SAMEH SOLIMAN
Dr. Sameh Soliman is an Associate Professor of Ophthalmology at the University of Alexandria, Egypt. After completing his ophthalmology residency in Alexandria Egypt in 2007, he was interested in pediatric ophthalmology with major focus on retinoblastoma. He embarked a professional improvement journey spanning across Egypt, Switzerland and Canada under the supervision of well-known worldwide mentors including Dr. Brenda Gallie, Dr. Francis Munier and Dr. Nihal Elshakankiry. He obtained both master’s degree and Ph.D. in Ophthalmology in 2007 and 2012 respectively. He has conducted clinical research throughout his career, studying meticulously his outcomes from different angles and setting guidelines on how to proceed efficiently leading to many research projects and over 35 peer reviewed publications. Email: samehelsayedsoliman@yahoo.com
Objectives of the Course
At the completion of this course you will be able to:- An educational foundation to enhance clinical experience and care
- Consensus guidelines provided by more than 50 retinoblastoma specialists
- General principles of pathogenesis and genetics of retinoblastoma
- General principles for diagnosis and management of retinoblastoma
Target Audience
Ophthalmologists (General and Ophthalmic Oncology), Oncologists (General and Pediatric), Radiation Oncologists, Pathologists (General and Ophthalmic), Resident Ophthalmologists, Oncologists, Radiation Oncologists, Social Workers, and Psychologists)Disclaimer
DocMode acknowledges that no educational grants were received for the creation of this Internet Enduring activity.Certification of Participation
Provided by: The Eye Cancer FoundationLecture FAQs
Firefox, Chrome, Safari and Internet Explorer
We generally encourage the use of, and fully support only, the latest version.